Css LLC Cassava Sciences Inc Put Options Transaction History

Css LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$16.33 - $51.06 $489,899 - $1.53 Million	30,000 New	30,000 $1.26 Million
Q2 2022 Aug 15, 2022	SELL	$17.22 - $38.47 $752,514 - $1.68 Million	-43,700 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$32.6 - $53.05 $280,360 - $456,230	8,600 Added 24.5%	43,700 $1.62 Million
Q4 2021 Feb 14, 2022	SELL	$36.77 - $90.91 $1.43 Million - $3.54 Million	-38,900 Reduced 52.57%	35,100 $1.54 Million
Q3 2021 Nov 15, 2021	BUY	$41.79 - $135.3 $1.58 Million - $5.13 Million	37,900 Added 104.99%	74,000 $4.59 Million
Q2 2021 Aug 16, 2021	BUY	$32.15 - $89.72 $1.16 Million - $3.24 Million	36,100 New	36,100 $3.08 Million

196

13.8M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $101M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.